Davern Capital Partners as of Dec. 31, 2025
Portfolio Holdings for Davern Capital Partners
Davern Capital Partners holds 14 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pfizer (PFE) | 16.4 | $51M | 2.0M | 24.90 | |
| Regeneron Pharmaceuticals (REGN) | 13.1 | $41M | 52k | 771.87 | |
| Biontech Se Sponsored Ads (BNTX) | 11.4 | $35M | 371k | 95.20 | |
| Royalty Pharma Shs Class A (RPRX) | 10.5 | $33M | 841k | 38.64 | |
| Argenx Se Sponsored Adr (ARGX) | 9.7 | $30M | 36k | 840.95 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 7.4 | $23M | 1.1M | 21.74 | |
| Roivant Sciences SHS (ROIV) | 7.2 | $22M | 1.0M | 21.70 | |
| Ionis Pharmaceuticals (IONS) | 6.1 | $19M | 239k | 79.11 | |
| Natera (NTRA) | 5.8 | $18M | 79k | 229.09 | |
| Eli Lilly & Co. (LLY) | 2.9 | $8.9M | 8.3k | 1074.68 | |
| Miragen Therapeutics (VRDN) | 2.6 | $8.1M | 262k | 31.12 | |
| Mineralys Therapeutics (MLYS) | 2.5 | $7.6M | 211k | 36.29 | |
| Cg Oncology (CGON) | 2.2 | $6.7M | 162k | 41.52 | |
| Abivax Sa Sponsored Ads (ABVX) | 2.1 | $6.5M | 49k | 134.85 |
